Multitude Therapeutics is Drug Discovery in China that focus on immuno-oncology antibodies business. Founded in 2019. They cover business area such as developer, new drug, tumor, novel antibody-drug conjugate, adc, CAR-Ts, immuno-oncology, health professional, cancer drug.
2019
( 5 years old in 2024 )
Immuno-oncology Antibodies
-
1-3F, Building 1, Juke Biological Park
No. 333 Guiping Road, Xuhui District
Shanghai
China
Private
developernew drugtumornovel antibody-drug conjugateadcCAR-Tsimmuno-oncologyhealth professionalcancer drug
* We use standard office opening hours in near Multitude Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Multitude Therapeutics is Drug Discovery business from China that founded in 2019 (5 years old in 2024), Multitude Therapeutics business is focusing on Immuno-oncology Antibodies.
Multitude Therapeutics headquarter office and corporate office address is located in 1-3F, Building 1, Juke Biological Park No. 333 Guiping Road, Xuhui District Shanghai China.
Multitude Therapeutics was founded in China.
In 2024, Multitude Therapeutics is currently focus on immuno-oncology antibodies sector.
Above is snippet of Google Trends for "immuno-oncology antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Multitude Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
